Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials
This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were strati...
Saved in:
| Published in | Pain Research and Treatment Vol. 2012; no. 2012; pp. 208 - 213 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cairo, Egypt
Hindawi Limiteds
01.01.2012
Hindawi Puplishing Corporation Hindawi Publishing Corporation |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user (n=137), placebo NSAID/APAP user (n=82), duloxetine NSAID/APAP nonuser (n=206), and placebo NSAID/APAP nonuser (n=156). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant (P=0.31) suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users. |
|---|---|
| AbstractList | This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user (n = 137), placebo NSAID/APAP user (n = 82), duloxetine NSAID/APAP nonuser (n = 206), and placebo NSAID/APAP nonuser (n = 156). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant (P = 0.31) suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users.This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user (n = 137), placebo NSAID/APAP user (n = 82), duloxetine NSAID/APAP nonuser (n = 206), and placebo NSAID/APAP nonuser (n = 156). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant (P = 0.31) suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users. This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user (n=137), placebo NSAID/APAP user (n=82), duloxetine NSAID/APAP nonuser (n=206), and placebo NSAID/APAP nonuser (n=156). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant (P=0.31) suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users. This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user (), placebo NSAID/APAP user (), duloxetine NSAID/APAP nonuser (), and placebo NSAID/APAP nonuser (). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant () suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users. This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen (APAP). Data were pooled from two 13-week randomized trials in patients with CLBP who were stratified according to NSAID/APAP use at baseline: duloxetine NSAID/APAP user ( n = 137), placebo NSAID/APAP user ( n = 82), duloxetine NSAID/APAP nonuser ( n = 206), and placebo NSAID/APAP nonuser ( n = 156). NSAID/APAP users were those patients who took NSAID/APAP for at least 14 days per month during 3 months prior to study entry. An analysis of covariance model that included therapy, study, baseline NSAID/APAP use (yes/no), and therapy-by-NSAID/APAP subgroup interaction was used to assess the efficacy. The treatment-by-NSAID/APAP use interaction was not statistically significant ( P = 0.31) suggesting no substantial evidence of differential efficacy for duloxetine over placebo on pain reduction or improvement in physical function between concomitant NSAID/APAP users and non-users. |
| Author | Liu, Peng Skljarevski, Vladimir Zhang, Shuyu Martinez, James M. Ahl, Jonna |
| AuthorAffiliation | 1 Lilly Research Laboratories, Eli Lilly and Company, Drop Code 1542, Indianapolis, IN 46285, USA 2 Lilly USA, LLC., Drop Code 4133, Indianapolis, IN 46285, USA |
| AuthorAffiliation_xml | – name: 1 Lilly Research Laboratories, Eli Lilly and Company, Drop Code 1542, Indianapolis, IN 46285, USA – name: 2 Lilly USA, LLC., Drop Code 4133, Indianapolis, IN 46285, USA |
| Author_xml | – sequence: 1 fullname: Ahl, Jonna – sequence: 2 fullname: Liu, Peng – sequence: 3 fullname: Zhang, Shuyu – sequence: 4 fullname: Martinez, James M. – sequence: 5 fullname: Skljarevski, Vladimir |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22550577$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v1DAQhiNUREvpiTPIRwSE2s6HEw5Iy26hlVawglYcrVnH7rpN7MV2uiz_mf-Ao7QrqJCIFHk88_h9Lc88TvaMNTJJnhL8hpCiOKaY0GNal4zgB8kBxTVOYxrv7eKc7idH3l_h-BU4Lxh-lOxTGpmCsYPk14lSWoDYIjAN-gpKhi2yCs361v6QQRuJtEELCFqa4NFGhxWarpw1WqC53aD3IK5jOTLfVhZdeNmgG-l879FMN-iTDUMOTa0RttMBTIg544N0VjfQookJOj0zqoWug2DdFs1cf-mRdWgiZIBOG7teSfMWTdDC-oBOrYiBbaPPxEC79doP16XoS7x_tPgpm9do0YKQS5tG2-BsO8DnTkPrnyQPVVzk0e16mFx8ODmfnqbzzx_PppN5CgVmIW2EWOYCV6zJ6yZGRUMlrsu6UlnOWA2AcUmzJctkWUIlSM1qVVdCSVwpqhrIDpN3o-66X3ayEfHtHLR87XQHbsstaP53xegVv7Q3PMtoXtMqCry4FXD2ey994J32QrYtGGl7zwkmhLCCkjyiz__02pnc9TgCZASEs947qbiInQh6eBzQbdTiwyjxYZT4OErxzKt7Z-5k_02_HOmVNg1s9H_gZyMsIyIV7OC8JFlOYn0-1kE7HTS_sr2LnfZ8EVVKXMQfj4qDJiYMV2QYbnZ_U3FKsuw3aFf3iw |
| CitedBy_id | crossref_primary_10_1002_14651858_CD012382 crossref_primary_10_1002_14651858_CD001703_pub4 |
| Cites_doi | 10.4088/JCP.09r05786blu 10.1016/S0140-6736(99)01312-4 10.1016/S0304-3959(99)00082-2 10.1111/j.1468-1331.2009.02648.x 10.1097/00007632-198709001-00007 10.1111/j.1365-2036.2007.03541.x 10.1016/j.spinee.2007.10.006 10.1097/BRS.0b013e3181d3cef6 10.1097/00007632-198303000-00004 10.7326/0003-4819-147-7-200710020-00008 10.1016/j.amjcard.2009.01.014 10.1007/s00586-010-1541-4 10.1001/archinte.163.1.59 10.1016/S0304-3959(98)00064-5 10.1007/s10195-009-0077-z |
| ContentType | Journal Article |
| Contributor | Liu, Peng Skljarevski, Vladimir Zhang, Shuyu Ahl, Jonna Martinez, James M |
| Contributor_xml | – sequence: 1 fullname: Ahl, Jonna – sequence: 2 fullname: Liu, Peng – sequence: 3 fullname: Zhang, Shuyu – sequence: 4 fullname: Martinez, James M – sequence: 5 fullname: Skljarevski, Vladimir |
| Copyright | Copyright © 2012 Vladimir Skljarevski et al. Copyright © 2012 Vladimir Skljarevski et al. 2012 |
| Copyright_xml | – notice: Copyright © 2012 Vladimir Skljarevski et al. – notice: Copyright © 2012 Vladimir Skljarevski et al. 2012 |
| DBID | 188 ADJCN AHFXO RHU RHW RHX AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1155/2012/296710 |
| DatabaseName | Chinese Electronic Periodical Services (CEPS) الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2090-1550 |
| Editor | Ortiz, Mario I. |
| Editor_xml | – sequence: 1 givenname: Mario I. surname: Ortiz fullname: Ortiz, Mario I. |
| EndPage | 213 |
| ExternalDocumentID | PMC3324928 22550577 10_1155_2012_296710 461341 P20160516005_201212_201708100007_201708100007_208_213 |
| Genre | Journal Article |
| GroupedDBID | 188 24P 2UF 4.4 53G 5VS AAJEY ABDBF ADBBV ADRAZ AINHJ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CEFSP CNMHZ DIK EBS EJD ESX GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IL9 INH INR ITC KQ8 M48 M~E OK1 PGMZT RHX RNS RPM TUS UZ5 3V. 8G5 ABUWG ADJCN AFKRA AHFXO AZQEC BENPR BPHCQ CCPQU DWQXO GNUQQ GUQSH H13 M2O PADUT PIMPY PQQKQ PROAC RHU RHW 0R~ AAYXX ACCMX ACUHS CITATION NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY 5PM |
| ID | FETCH-LOGICAL-a507t-dccb4c087d49db4c5d2e09698f34779aa00623b73e66a8c1979f98cfe08f2fda3 |
| IEDL.DBID | M48 |
| ISSN | 2090-1542 2090-1550 |
| IngestDate | Thu Aug 21 14:12:50 EDT 2025 Thu Jul 10 23:19:03 EDT 2025 Wed Feb 19 02:05:06 EST 2025 Thu Apr 24 22:56:46 EDT 2025 Tue Jul 01 01:40:26 EDT 2025 Sun Jun 02 19:12:12 EDT 2024 Tue Nov 26 17:10:18 EST 2024 Tue Oct 01 22:51:40 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2012 |
| Language | English |
| License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a507t-dccb4c087d49db4c5d2e09698f34779aa00623b73e66a8c1979f98cfe08f2fda3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Academic Editor: Mario I. Ortiz |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2012/296710 |
| PMID | 22550577 |
| PQID | 1011175214 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3324928 proquest_miscellaneous_1011175214 pubmed_primary_22550577 crossref_citationtrail_10_1155_2012_296710 crossref_primary_10_1155_2012_296710 hindawi_primary_10_1155_2012_296710 emarefa_primary_461341 airiti_journals_P20160516005_201212_201708100007_201708100007_208_213 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-01-01 |
| PublicationDateYYYYMMDD | 2012-01-01 |
| PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cairo, Egypt |
| PublicationPlace_xml | – name: Cairo, Egypt – name: United States |
| PublicationTitle | Pain Research and Treatment |
| PublicationTitleAlternate | Pain Res Treat |
| PublicationYear | 2012 |
| Publisher | Hindawi Limiteds Hindawi Puplishing Corporation Hindawi Publishing Corporation |
| Publisher_xml | – name: Hindawi Limiteds – name: Hindawi Puplishing Corporation – name: Hindawi Publishing Corporation |
| References | (4) 2007; 147 GuyW.ECDEU Assessment Manual for Psychopharmacology1976National Government Publication (2) 2000; 3 (9) 2010; 71 (13) 1987; 12 (7) 2003; 163 (17) 1998; 76 (8) 2008; 27 (11) 2010; 35 CymbaltaPrescribing Information2011Indianapolis, IN, USAEli Lilly and Company (19) 2009; 10 (12) 2009; 16 (14) 1994; 23 (6) 2009; 103 (15) 1983; 8 (5) 2011; 20 (3) 2008; 8 (1) 1999; 354 (18) 1999; 83 11 12 17 (16) 1976 18 19 1 3 5 6 7 8 9 (10) 2011 |
| References_xml | – reference: CymbaltaPrescribing Information2011Indianapolis, IN, USAEli Lilly and Company – volume: 20 start-page: 40 issue: 1 year: 2011 end-page: 50 ident: 5 article-title: A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain – volume: 16 start-page: 1041 issue: 9 year: 2009 end-page: 1048 ident: 12 article-title: A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain – volume: 8 start-page: 141 issue: 2 year: 1983 end-page: 144 ident: 15 article-title: A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain – volume: 103 start-page: 1227 issue: 9 year: 2009 end-page: 1237 ident: 6 article-title: An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs – volume: 27 start-page: 31 issue: 1 year: 2008 end-page: 40 ident: 8 article-title: Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs – volume: 35 start-page: E578 issue: 13 year: 2010 end-page: E585 ident: 11 article-title: Efficacy and safety of duloxetine in patients with chronic low back pain – volume: 83 start-page: 137 issue: 2 year: 1999 end-page: 145 ident: 18 article-title: Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity – volume: 147 start-page: 505 issue: 7 year: 2007 end-page: 514 ident: 4 article-title: Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline – volume: 3 start-page: 167 issue: 2 year: 2000 end-page: 192 ident: 2 article-title: Epidemiology of low back pain – volume: 71 start-page: 1565 issue: 12 year: 2010 end-page: 1575 ident: 9 article-title: Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms – volume: 10 start-page: 185 issue: 4 year: 2009 end-page: 191 ident: 19 article-title: Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain – volume: 23 start-page: 129 issue: 2 year: 1994 end-page: 138 ident: 14 article-title: Pain assessment: global use of the Brief Pain Inventory – reference: GuyW.ECDEU Assessment Manual for Psychopharmacology1976National Government Publication – volume: 12 start-page: S16 year: 1987 end-page: S21 ident: 13 article-title: Scientific approach to the assessment and management of activity-related spinal disorders (the Quebec Task Force) – volume: 76 start-page: 287 issue: 3 year: 1998 end-page: 296 ident: 17 article-title: A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain – volume: 354 start-page: 581 issue: 9178 year: 1999 end-page: 585 ident: 1 article-title: Epidemiological features of chronic low-back pain – volume: 8 start-page: 21 issue: 1 year: 2008 end-page: 27 ident: 3 article-title: Evidence-informed management of chronic low back pain with adjunctive analgesics – volume: 163 start-page: 59 issue: 1 year: 2003 end-page: 64 ident: 7 article-title: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding a population-based cohort study – ident: 9 doi: 10.4088/JCP.09r05786blu – volume: 3 start-page: 167 issue: 2 year: 2000 ident: 2 publication-title: Pain Physician – ident: 1 doi: 10.1016/S0140-6736(99)01312-4 – ident: 18 doi: 10.1016/S0304-3959(99)00082-2 – ident: 12 doi: 10.1111/j.1468-1331.2009.02648.x – volume: 12 start-page: S16 year: 1987 ident: 13 publication-title: Spine doi: 10.1097/00007632-198709001-00007 – ident: 8 doi: 10.1111/j.1365-2036.2007.03541.x – ident: 3 doi: 10.1016/j.spinee.2007.10.006 – year: 2011 ident: 10 – ident: 11 doi: 10.1097/BRS.0b013e3181d3cef6 – volume: 8 start-page: 141 issue: 2 year: 1983 ident: 15 publication-title: Spine doi: 10.1097/00007632-198303000-00004 – volume: 147 start-page: 505 issue: 7 year: 2007 ident: 4 publication-title: Annals of Internal Medicine doi: 10.7326/0003-4819-147-7-200710020-00008 – ident: 6 doi: 10.1016/j.amjcard.2009.01.014 – ident: 5 doi: 10.1007/s00586-010-1541-4 – ident: 7 doi: 10.1001/archinte.163.1.59 – year: 1976 ident: 16 – volume: 23 start-page: 129 issue: 2 year: 1994 ident: 14 publication-title: Annals of the Academy of Medicine Singapore – ident: 17 doi: 10.1016/S0304-3959(98)00064-5 – ident: 19 doi: 10.1007/s10195-009-0077-z |
| SSID | ssj0000504570 |
| Score | 1.8796791 |
| Snippet | This subgroup analysis assessed the efficacy of duloxetine in patients with chronic low back pain (CLBP) who did or did not use concomitant nonsteroidal... |
| SourceID | pubmedcentral proquest pubmed crossref hindawi emarefa airiti |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 208 |
| SummonAdditionalLinks | – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdg0hAviK-x8KVD7AkRkThJnfBW2k4FsamCVfQtchyHRrQ2alKN8T_zP3CXpBUtE-IhipNcHEv-Ob7znX_H2InW5N6T3PUzX7ohWihupiIyXMNAFLlCfY52I5-d98bT8MMsmnUBstXfLnyc7dA89_kbnvQE7aS6ifgim3w8266keBGqJU1WOO4lnos6Ae824u29jZOMLIkqaGcOOtRLiQWcmA7nZAZfltcpm_sxk39MQqd32Z1Oe4R-29332A1t7rNbZ51__AH7NSJGCKmuQJocPstC11dgCxiuF_YHbW7WUBqYtFyqFdAiLHT0uPDRXsI7qb7hY5T5MrcwrXQOFLaxrmBY5nBua7oHA2sQpyXlH8Z7hqgWbJlTu0xduu9NgShbNt57GK7WXyuwK-grXctlaYjGwLyFPlCWYBhbhQW7wO9s2FGouRw-YfvxEz91_homtNKfWXfQRtWT8EUzbB6y6enoYjB2u4QOrkS1s3ZzpbJQebHIwyTHUpRzjSZUEhdBKEQiJe3oDDIR6F5PxspPRFIksSq0Fxe8yGVwxA6MNfqYgcYe8yKtBCp8oYySRHsF2oI60RkqWCJw2Kjt67Qbk1U64cSmF-HhRSnBwud0EqgUNQ7d_Ys45T7W82oDlVR1rOmUvGORNtZT1NaUtgBz2MlW-HtLFnK92FGHua1U2CNiPYe97CD479dfbOCZ4r-AHDzSaLuuKFyPmFe5HzrsUQvXbUX43yZbVDhM7AB5K0A847tPTDlv-MaDgGgl48f_1bon7DZdtatUT9lBvVrrZ6i31dnzZtj-Bp0-N1g priority: 102 providerName: Hindawi Publishing |
| Title | Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials |
| URI | https://www.airitilibrary.com/Article/Detail/P20160516005-201212-201708100007-201708100007-208-213 https://search.emarefa.net/detail/BIM-461341 https://dx.doi.org/10.1155/2012/296710 https://www.ncbi.nlm.nih.gov/pubmed/22550577 https://www.proquest.com/docview/1011175214 https://pubmed.ncbi.nlm.nih.gov/PMC3324928 |
| Volume | 2012 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbG0BAviNugXKaD2BMikGudICFU2o6C6DSNVfQtchyHRrQ2NKm28p_5D5yTpBWtKsRDWyc5cazmc_ydHPs7jB0rReE94VpO4gjLRw_FSmRAjqvv8SyVyOdoNfLwtD0Y-Z_GwXiPrZJxNn9gsdO1o3xSo_n01dXP5Tvs8G-rDh8E6L877ms3anNaanUdhyROPXTY8Pxa5BuZS5U4zrUj2yJa3qzV2zofxyGRk5rQxjB1oGYCCzh2HUzIU77Md_HR7WmVf41TJ7fZrYZgQqdGxB22p_RddmPYhNDvsd99Eo0QcglCp_BFZKpcgsmgt5iaK1r_rCDXcFbLrRZA72mhUdCFz-YS3gv5HQ-jzdeJgVGhUqCZHYsCenkKp6akfdA1GqGcU4pi3KdJjcHkKbVLl7n1UWcIxFkV4IfefPGtADOHjlSlmOWalA70G-gAJRKGgZFYMFO8zkpAhZrrwjm2Hy_xS6Uv4YyCAYmxuvXEezK-qHrWfTY66V90B1aT88ESyExLK5Uy8aUd8tSPUiwFqavQy4rCzPM5j4SgRZ9ewj3VbotQOhGPsiiUmbLDzM1S4R2yfW20eshA4R2zAyU5ckJfBFGk7AzdRRWpBDkY91qsX9_reIW6-Mwlwb0AP3YQEywcl3448qYq5ru9Ecaug_W8WEEllo2wOuX3mMaVgxXUNcU1wFrseG38o9YT2W122GBubeW3SXuvxZ43EPz36c9W8IzxcUExIKGVWRQ0o4_EWV3Hb7EHNVzXFeGjndxV3mJ8A8hrA5Ii3zyi80klSe55pDwZPvqP6z5mN6ml9WusJ2y_nC_UUyR2ZXLErn0YO0dV18Xv88H4D85hR40 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+Safety+of+Duloxetine+in+Patients+with+Chronic+Low+Back+Pain+Who+Used+versus+Did+Not+Use+Concomitant+Nonsteroidal+Anti-Inflammatory+Drugs+or+Acetaminophen%3A+A+Post+Hoc+Pooled+Analysis+of+2+Randomized%2C+Placebo-Controlled+Trials&rft.jtitle=Pain+research+and+treatment&rft.au=Skljarevski%2C+Vladimir&rft.au=Liu%2C+Peng&rft.au=Zhang%2C+Shuyu&rft.au=Ahl%2C+Jonna&rft.date=2012-01-01&rft.issn=2090-1550&rft.eissn=2090-1550&rft.volume=2012&rft.spage=296710&rft_id=info:doi/10.1155%2F2012%2F296710&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2090-1542&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2090-1542&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2090-1542&client=summon |